−9.0621USD
−36.07 MUSD
2.64 M
About Eloxx Pharmaceuticals, Inc.
Sector
Industry
CEO
Sumit Aggarwal
Website
Headquarters
Watertown
Employees (FY)
18
Founded
2017
FIGI
BBG000BGH306
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Watertown, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ELOX is 0.8025 USD — it has increased by 0.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Eloxx Pharmaceuticals, Inc. stocks are traded under the ticker ELOX.
Eloxx Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ELOX stock is 2.37% volatile and has beta coefficient of 4.43. Check out the list of the most volatile stocks — is Eloxx Pharmaceuticals, Inc. there?
One year price forecast for Eloxx Pharmaceuticals, Inc. has a max estimate of 30.0000 USD and a min estimate of 30.0000 USD.
ELOX earnings for the last quarter are −1.16 USD per share, whereas the estimation was −1.97 USD resulting in a 40.89% surprise. The estimated earnings for the next quarter are −1.43 USD per share. See more details about Eloxx Pharmaceuticals, Inc. earnings.
Eloxx Pharmaceuticals, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 700.00 K USD.
Yes, you can track Eloxx Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ELOX stock has fallen by 21.32% compared to the previous week, the month change is a 15.53% fall, over the last year Eloxx Pharmaceuticals, Inc. has showed a 87.63% decrease.
ELOX net income for the last quarter is −3.59 M USD, while the quarter before that showed −4.34 M USD of net income which accounts for 17.25% change. Track more Eloxx Pharmaceuticals, Inc. financial stats to get the full picture.
Today Eloxx Pharmaceuticals, Inc. has the market capitalization of 2.52 M, it has decreased by 5.61% over the last week.
No, ELOX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ELOX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eloxx Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 18.00 employees. See our rating of the largest employees — is Eloxx Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eloxx Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eloxx Pharmaceuticals, Inc. stock shows the sell signal. See more of Eloxx Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Eloxx Pharmaceuticals, Inc. future price: according to them, ELOX price has a max estimate of 30.00 USD and a min estimate of 30.00 USD. Read a more detailed Eloxx Pharmaceuticals, Inc. forecast: see what analysts think of Eloxx Pharmaceuticals, Inc. and suggest that you do with its stocks.